Mercado mundial de nutrición parenteral: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

El cuerpo recibe nutrientes de la alimentación parenteral, entre ellos azúcar, carbohidratos, proteínas, grasas, electrolitos y oligoelementos. Estos nutrientes son esenciales para mantener altos niveles de fuerza, hidratación y energía.

Data Bridge Market Research analiza que el mercado de nutrición parenteral, que fue de USD 6.3 mil millones en 2021, se disparará hasta USD 9.38 mil millones para 2029, y se espera que experimente una CAGR del 5,10% durante el período de pronóstico de 2022 a 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis experto en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Definición de mercado

In both developing and established economies, malnourishment is a major contributor to inflammatory bowel disease (IBD), which affects a significant portion of the population. On a larger scale, total parenteral nutrition (TPN) serves as a major treatment for IBD by addressing the nutritional shortage brought by the conclusion of intestinal failure.

Parenteral Nutrition Market Dynamics

Drivers

• Rising metabolic disorders

One of the key factors driving the expansion of the parenteral nutrition market in the present is the rise in metabolic disorders along with chronic diseases like diabetes. The parenteral nutrition industry will expand as a result of the rising rate of malnutrition in the world. Additionally, one of the main factors driving the expansion of the parenteral nutrition market is the ageing population, which is increasing.

• Increasing chronic diseases

Rapid modernization, poor dietary intake of a balanced diet, and the rising frequency of chronic diseases all contribute to the need for the parenteral nutrition industry.

• Increasing prevalence of malnutrition

The need for parenteral nutrition has increased as a result of the rising incidence of malnutrition around the world. This demand is anticipated to favourably influence the industry's development. Additionally, there was a strong demand for intravenous feeding as a result of the supportive government initiatives to lessen the impact of malnutrition.

Opportunities

The rise in childhood malnutrition, particularly in developing and emerging economies worldwide, is anticipated to fuel the growth of the parenteral nutrition market. Additionally, the parenteral nutrition industry would have promising growth prospects due to the need for parenteral nutrition to properly balance amino acids, lipids, vitamins, minerals, and other nutrients.

 Restraints/Challenges

Despite this, the acceptability of parenteral feeding products is subject to stringent government regulations, particularly in emerging economies, which will restrain the market's expansion. One of the main obstacles to the growth of the parenteral nutrition industry in the anticipated term is the lack of information among people in developed nations.

This parenteral nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the parenteral nutrition market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Parenteral Nutrition Market

The parenteral nutrition market value has been impacted by the extraordinary global health issue caused by the COVID-19 virus outbreak. Parenteral nutrition played a crucial part in the treatment of malnutrition caused by the COVID-19 infection in patients all over the world. A severe lack of appetite brought on by the COVID-19 infection was accompanied by other symptoms that worsened immune defences and caused muscle mass loss. In response to this illness, hospitals and clinics have increased the number of healthcare facilities available for patients who need diet tailored to their sickness. Such advancements are likely to increase patient demand for and adoption of intravenous nutrition administration.

Recent Development

• In July 2021, Micrel Medical, a manufacturer of medical devices with a focus on infusion therapy, and Baxter Healthcare (Baxter) inked a contract. In accordance with this agreement, the businesses would market the infusion pump Micrel Mini Rythmic PN+ for parenteral nutrition (PN).
• Sep 2020: The U.S. Food and Drug Administration (FDA) gave its approval to Baxter International's new Clinimix Injections and Clinimix E Injections formulations. It is easier to reach patient protein targets with the new Clinimix formulations because they contain up to 80 g/L of amino acids, the highest amount of protein in any multi-chamber bag currently available in the United States also contain less fluid and dextrose than previous formulations.

 Global Parenteral Nutrition Market Scope

The parenteral nutrition market is segmented on the basis of nutrition type, consumer type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Nutrient Type

• Carbohydrates
• Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins and Minerals

Consumer Type

• Children and New-born
• Adults

End-User

• Clinic
• Hospital
• Others

Parenteral Nutrition Market Regional Analysis/Insights

The parenteral nutrition market is analysed and market size insights and trends are provided by country, nutrition type, consumer type, and end-user as referenced above.

The countries covered in the parenteral nutrition market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

América del Norte domina el mercado de nutrición parenteral debido a la importancia de los enormes costos de investigación por parte de agencias gubernamentales y entidades privadas en el sector de la salud.

Se espera que la región Asia-Pacífico aumente durante el período de pronóstico como resultado del desarrollo económico de las naciones emergentes y de las iniciativas gubernamentales apropiadas para mejorar la infraestructura de atención médica y las prácticas de reembolso.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.

Análisis del panorama competitivo y de la cuota de mercado de la nutrición parenteral

El panorama competitivo del mercado de nutrición parenteral proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de nutrición parenteral.

Algunos de los principales actores que operan en el mercado de nutrición parenteral son:

• Baxter (Estados Unidos)
• Fábrica farmacéutica Otsuka, Inc. (Tokio)
• Forbes Media LLC (Estados Unidos)
• Kelun.com (China)
• Vifor Pharma Management Ltd. (Suiza)
• AbbVie Inc. (Estados Unidos)
• B. Braun Melsungen AG (Alemania)
• Fresenius SE & Co. KGaA (Alemania)
• Grifols SA (España)
• Pfizer, Inc. (Estados Unidos)
• UCI Medical, Inc. (Estados Unidos)
• Anhui Medipharm Co., Ltd. (China)
• aculife (India)
• Servona GmbH (Alemania)

SKU-34734